Spravato® Treatment

A prescription nasal spray for adults whose depression hasn’t improved with other antidepressants.
A patient speaking with a mental health professional

What is Spravato?

Spravato is an FDA-approved prescription nasal spray containing esketamine. For adults with treatment-resistant depression, it may be prescribed on its own or with an oral antidepressant. Your clinician will help decide how it fits into your care. It is given in a healthcare setting rather than taken at home. Spravato is a specific, FDA-approved medication; it is different from intravenous ketamine treatment.

Who may qualify?

Spravato may be considered for adults whose depression has not improved adequately after at least two different antidepressants taken at an adequate dose and for an adequate length of time. Meeting that history does not automatically mean it is the right choice. An evaluation includes your symptoms, previous medications, medical history, current medicines, and treatment goals. Your clinician also considers blood pressure, relevant vascular conditions, and risks related to substance use. Learn about our clinical evaluations

What happens during a Spravato session?

Treatment takes place in person. Allow time for preparation, dosing, and monitoring, and arrange a ride home before your appointment.

Prepare together

Your care team checks your blood pressure and reviews how you are feeling. Follow your clinician’s instructions, including avoiding food for two hours and liquids for 30 minutes before treatment.

Take the nasal spray

You administer the prescribed nasal spray yourself under the direct supervision of a healthcare professional. The team remains available throughout your visit.

Rest and be monitored

You stay for at least two hours after dosing. Monitoring includes breathing, oxygen levels, blood pressure, and how you feel. A clinician determines when you are ready to leave.
Plan a ride home. Do not drive, operate machinery, or do activities requiring full alertness until the next day after a restful sleep.

Why REMS monitoring matters

Spravato is available through a Risk Evaluation and Mitigation Strategy (REMS) program. It requires certified treatment settings, patient enrollment for outpatient treatment, and supervised dosing and monitoring. These safeguards address risks including sedation, dissociation, respiratory depression, and abuse or misuse. Spravato is not dispensed for home use. Your clinician will explain the benefits, risks, and alternatives before you decide whether to proceed.

Insurance and cost

Coverage depends on your insurance plan and its medical-necessity requirements. Prior authorization may be needed, and coverage for the medicine and the treatment visit can differ. Before starting, ask about your benefits, authorization requirements, deductible, copay, and any out-of-pocket costs. An insurance plan being accepted by the practice does not guarantee Spravato coverage. Contact InnerRise with coverage questions

Spravato treatment FAQs

How often are treatment sessions?For treatment-resistant depression, the usual schedule begins with twice-weekly sessions for four weeks, followed by weekly sessions for four weeks. After that, treatment may be weekly or every two weeks. Your clinician adjusts the plan based on your response and ongoing needs.
What side effects might I experience?Possible effects include dizziness, nausea, sleepiness, feeling disconnected from yourself or your surroundings, and increased blood pressure. More serious risks include breathing problems. Tell the care team about any symptoms during or after treatment.
Will I need to keep taking an antidepressant?Spravato is approved for treatment-resistant depression either alone or with an oral antidepressant. Your clinician will make an individualized recommendation. Do not change or stop your medications without discussing it with your prescriber.
Can I receive Spravato through telehealth?No. Spravato dosing and the required monitoring take place in person at a certified healthcare setting. Contact our Walpole office to discuss the evaluation process and appointment availability.
How will I know whether treatment is helping?You and your clinician will review changes in symptoms, daily functioning, and side effects over time. Results vary, and treatment is reassessed regularly. No particular response or recovery timeline can be guaranteed.

Talk with InnerRise about Spravato

Have questions about esketamine treatment near Walpole? A conversation with our team can help you understand the next step. 841 Main Street, Suite 1B Walpole, MA 02081